Zobrazeno 1 - 10
of 127
pro vyhledávání: '"Michael, Rosenzweig"'
Autor:
Raya Aliakbar, Olga Manouvakhova, Cindy Wong, Myo Htut, Johannes Pulst-Korenberg, Murali Janakiram, Michael Rosenzweig, Scott R. Goldsmith, Xenos L. Mason
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
We report on a patient with ciltacabtagene autoleucel-induced movement and neurocognitive toxicity, which was refractory to immunosuppression but responsive to combination dopaminergic therapy (carbidopa/levodopa, ropinirole, amantadine). Response wa
Externí odkaz:
https://doaj.org/article/d2ff20730bd2416e9f9c0c18ea2494ef
Autor:
Scott R. Goldsmith, May San-Rozano, Justine Katindoy, Janet Rattanapichetkul, Michael Rosenzweig
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
High-dose chemotherapy with autologous hematopoietic cell transplantation (AutoHCT) has long been an integral treatment modality for multiple myeloma and non-Hodgkin lymphoma. Over the past 25 years, numerous institutions have shifted this practice f
Externí odkaz:
https://doaj.org/article/12d0b65e3dc54a719e3bb4b535322638
Autor:
Yan Zhang, Michael Peel, Adrian Bot, Brittany Ross, Duy Nguyen, Michelle Nguyen, Theresa Hunter, Gregor Adams, Barzan A Sadiq, Haig Aghajanian, Ferran Soldevila, Daiki Matsuda, Yanjie Bao, Stuart A Sievers, John Li, Josephine Nguyen, Claudia Fernandez, Yi Kuo, James Vestal, Matthew Butcher, Jeffrey Chen, Stanley Zhang, Makan Khoshnejad, Donald Jhung, Steve Tanis, Michael Rosenzweig, Priya Karmali
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/19b7b54c372d4f1982326821a2571052
Autor:
Hadas Lewinsky, Emine G. Gunes, Keren David, Lihi Radomir, Matthias P. Kramer, Bianca Pellegrino, Michal Perpinial, Jing Chen, Ting-fang He, Anthony G. Mansour, Kun-Yu Teng, Supriyo Bhattacharya, Enrico Caserta, Estelle Troadec, Peter Lee, Mingye Feng, Jonathan Keats, Amrita Krishnan, Michael Rosenzweig, Jianhua Yu, Michael A. Caligiuri, Yosef Cohen, Olga Shevetz, Shirly Becker-Herman, Flavia Pichiorri, Steven Rosen, Idit Shachar
Publikováno v:
JCI Insight, Vol 8, Iss 14 (2023)
Externí odkaz:
https://doaj.org/article/fac6727535924d42be070993ae2438ba
Autor:
Corinna La Rosa, Flavia Chiuppesi, Yoonsuh Park, Qiao Zhou, Dongyun Yang, Ketevan Gendzekhadze, Minh Ly, Jing Li, Teodora Kaltcheva, Sandra Ortega Francisco, Miguel-Angel Gutierrez, Haris Ali, Salman Otoukesh, Idoroenyi Amanam, Amandeep Salhotra, Vinod A. Pullarkat, Ibrahim Aldoss, Michael Rosenzweig, Ahmed M. Aribi, Anthony S. Stein, Guido Marcucci, Sanjeet Singh Dadwal, Ryotaro Nakamura, Stephen J. Forman, Monzr M. Al Malki, Don J. Diamond
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
In the current post-pandemic era, recipients of an allogeneic hematopoietic stem cell transplant (HCT) deserve special attention. In these vulnerable patients, vaccine effectiveness is reduced by post-transplant immune-suppressive therapy; consequent
Externí odkaz:
https://doaj.org/article/f9e29286714a431b829fd3e49d2e0728
Autor:
Flavia Chiuppesi, Sandra Ortega-Francisco, Miguel-Angel Gutierrez, Jing Li, Minh Ly, Katelyn Faircloth, Jada Mack-Onyeike, Corinna La Rosa, Sandra Thomas, Qiao Zhou, Jennifer Drake, Cynthia Slape, Paolo Fernando, Wasima Rida, Teodora Kaltcheva, Alba Grifoni, Alessandro Sette, Angela Patterson, Shannon Dempsey, Brian Ball, Haris Ali, Amandeep Salhotra, Anthony Stein, Nitya Nathwani, Michael Rosenzweig, Liana Nikolaenko, Monzr M. Al Malki, Jana Dickter, Deepa D. Nanayakkara, Alfredo Puing, Stephen J. Forman, Randy A. Taplitz, John A. Zaia, Ryotaro Nakamura, Felix Wussow, Don J. Diamond, Sanjeet S. Dadwal
Publikováno v:
Vaccines, Vol 11, Iss 9, p 1492 (2023)
Hematopoietic cell transplantation (HCT) and chimeric antigen receptor (CAR)-T cell patients are immunocompromised, remain at high risk following SARS-CoV-2 infection, and are less likely than immunocompetent individuals to respond to vaccination. As
Externí odkaz:
https://doaj.org/article/0f069907108b4e64a02598493f2e56e5
Autor:
Vikram J. Premkumar, Suzanne Lentzsch, Samuel Pan, Divaya Bhutani, Joshua Richter, Sundar Jagannath, Michaela Liedtke, Arnaud Jaccard, Ashutosh D. Wechalekar, Raymond Comenzo, Vaishali Sanchorawala, Bruno Royer, Michael Rosenzweig, Jason Valent, Stefan Schönland, Rafael Fonseca, Sandy Wong, Prashant Kapoor
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Venetoclax is efficacious in relapsed/refractory t(11;14) multiple myeloma, thus warranting investigation in light-chain amyloidosis (AL). This retrospective cohort includes 43 patients with previously treated AL, from 14 centers in the US a
Externí odkaz:
https://doaj.org/article/013c38376a484b75ab2ff3152ca40fbf
Autor:
Hadas Lewinsky, Emine G. Gunes, Keren David, Lihi Radomir, Matthias P. Kramer, Bianca Pellegrino, Michal Perpinial, Jing Chen, Ting-fang He, Anthony G. Mansour, Kun-Yu Teng, Supriyo Bhattacharya, Enrico Caserta, Estelle Troadec, Peter Lee, Mingye Feng, Jonathan Keats, Amrita Krishnan, Michael Rosenzweig, Jianhua Yu, Michael A. Caligiuri, Yosef Cohen, Olga Shevetz, Shirly Becker-Herman, Flavia Pichiorri, Steven Rosen, Idit Shachar
Publikováno v:
JCI Insight, Vol 6, Iss 4 (2021)
Multiple myeloma (MM) is characterized by an accumulation of malignant plasma cells (PCs) within the BM. The BM microenvironment supports survival of the malignant cells and is composed of cellular fractions that foster myeloma development and progre
Externí odkaz:
https://doaj.org/article/d7a411db996948a2b5bdffc9677fbefe
Autor:
Yun Wang, Long Cui, Peter Georgiev, Latika Singh, Yanyan Zheng, Ying Yu, Jeff Grein, Chunsheng Zhang, Eric S. Muise, David L. Sloman, Heidi Ferguson, Hongshi Yu, Cristina St. Pierre, Pranal J Dakle, Vincenzo Pucci, James Baker, Andrey Loboda, Doug Linn, Christopher Brynczka, Doug Wilson, Brian B Haines, Brian Long, Richard Wnek, Svetlana Sadekova, Michael Rosenzweig, Andrew Haidle, Yongxin Han, Sheila H. Ranganath
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
Prostaglandin E2 (PGE2), an arachidonic acid pathway metabolite produced by cyclooxygenase (COX)-1/2, has been shown to impair anti-tumor immunity through engagement with one or more E-type prostanoid receptors (EP1-4). Specific targeting of EP recep
Externí odkaz:
https://doaj.org/article/36e7a55740434d6e88a502ce5e86b72a
Autor:
Philip E. Brandish, Michael Rosenzweig, Sheila H. Ranganath, Derek Y. Chiang, Michael Meehl, Chunsheng Zhang, Andrey Loboda, Barbara Joyce-Shaikh, Yujie Qu, Jun Zhang, Peter Stivers, Sarah Javaid, Jeff Grein, Anannya Bhattacharya, Eric S. Muise, Latika Singh
Figure S1A-C - Dot plots and histograms from flow cytometry analysis of SK-MEL-5-educated M-MDSCs and PBMCs cultured in medium alone.Figure S1D - FACS result of cell surface staining of cytokine-induced M-MDSCs and PBMCs cultured in medium alone.Figu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5680bc3dd085554082920313a25bb51e
https://doi.org/10.1158/1541-7786.22527137
https://doi.org/10.1158/1541-7786.22527137